- Home
- BCAB vs DIT Comparison
BCAB vs DIT Comparison
Compare BCAB & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCAB | DIT |
|---|---|---|
| Founded | 2007 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 74.2M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BCAB | DIT |
|---|---|---|
| Price | $0.66 | $106.50 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 564.0 |
| Earning Date | 11-13-2025 | 01-20-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.92 |
| Revenue | N/A | ★ $2,254,788,287.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $119.57 |
| Revenue Growth | N/A | ★ 5.29 |
| 52 Week Low | $0.24 | $94.92 |
| 52 Week High | $1.43 | $156.99 |
Technical Indicators
Market Signals| Indicator | BCAB | DIT |
|---|---|---|
| Relative Strength Index (RSI) | 40.18 | 34.37 |
| Support Level | $0.74 | $103.41 |
| Resistance Level | $0.83 | $114.07 |
| Average True Range (ATR) | 0.08 | 1.82 |
| MACD | -0.01 | -0.67 |
| Stochastic Oscillator | 14.83 | 23.61 |
Price Performance
Historical ComparisonAbout BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.